INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 29, 2015 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,954 | -- | -- |
| Dec 16, 2015 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 16, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 16, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 16, 2015 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 16, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,921 | -- | -- |
| Dec 10, 2015 |
Director
Trans History: 466
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 1,199 | $547.50 | -- |
| Nov 10, 2015 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Open market or private sale of non-derivative or derivative security | 1,223 | $557.14 | -- |
| Oct 30, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 182,818 | -- | -- |
| Sep 21, 2015 |
Director
Trans History: 466
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 3,000 | $551.55 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.